Supernus Pharmaceuticals reported $7.86M in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 2018M 429M
Aerie Pharmaceuticals AERI:US $ -19.37M 16.52M
Aurora Cannabis Inc ACB:CN -1012177000 937.4M
Bristol Myers Squibb BMY:US $ 1421M 143M
Canopy Growth Corp WEED:CN C$ -2083148000 1.51B
Cara Therapeutics CARA:US $ -4206000 23.54M
Corcept Therapeutics CORT:US $ 27.41M 4.62M
Eisai 4523:JP Y 26898M 39301M
Eli Lilly And LLY:US $ 952.5M 950.4M
Endo International Ordinary Shares ENDP:US $ -71.97M 490.09M
Horizon Pharma HZNP:US $ 60.97M 143.29M
JAZZ PHA JAZZ:US $ 34.66M 33.02M
Lannett LCI:US $ -34.9M 46.19M
Marinus Pharmaceuticals MRNS:US $ -19.36M 8.94M
Pacira Pharmaceuticals PCRX:US $ 19.88M 13.05M
Perrigo Ordinary Shares PRGO:US $ -2.4M 12M
Pfizer PFE:US $ 9905M 2042M
Revance Therapeutics RVNC:US $ -64.34M 1.24M
Supernus Pharmaceuticals SUPN:US $ 7.86M 17.75M
Teva Pharmaceutical Industries TEVA:US $ -233M 722M
United Therapeutics UTHR:US $ 116M 123.9M
Xeris Pharmaceuticals Inc XERS:US -33714000 17.08M